The stigma around cannabis in the U.S. continues to fuel the various myths surrounding its use and its users. As such, proponents of cannabis continue to highlight the potential health benefits, while educating on legalization efforts and debunking historical myths.
In part 1 of our interview with cannabis advocate Dr. Rachel Knox, she described her outlook on the effect the incoming administration may have on cannabis, particularly medical marijuana. Currently, the FDA still has not recognized or approved the marijuana plant as medicine. This is slowly changing, as more and more studies prove the medical benefits of the plant. The scientific study of the chemicals in marijuana called cannabinoids has led to two FDA-approved medications in pill form. Scientific research has shown cannabis to treat symptoms, related but not limited to, glaucoma, multiple sclerosis, arthritis, cancer, AIDS, spinal cord injuries, anxiety, and insomnia.
Here, Knox provides some more thoughts on how cannabis legalization can potentially affect the industry.
Cannabis legalization, regulation, and access boils down to misunderstanding, greed, and fear.
I believe that legislators are attempting to heavily regulate a plant they do not understand, and as a result, are misregulating it. I believe that states’ collective focus on the projected tax revenues of their recreational markets is short-sighted as medical markets are actually much larger and growing. I also believe that cannabis and natural medicine as a whole threaten Big Pharma’s bottom line.
I anticipate that government will continue to participate in local overregulation and in Big Pharma’s acquisition and control over medical cannabis product manufacturing and distribution. The FDA is already selling Big Pharma patents they hold on cannabinoid profiles for therapeutic use. People believe that the federal government is not involved in legalization efforts, but they certainly are—just in a very different way than anticipated or desired.
Patients, cultivators, and manufacturers participating in the recreational market have to maintain their own standards.
I recommend these participants to demand, cultivate, and manufacture organic and pure products so that medicinal grade products remain on dispensary shelves. I recommend that medical advocates work with legislators to develop favorable regulations that lift strict and sub-therapeutic caps on cannabinoid content of those products.
I also recommend that people learn how to grow their own plants if they live in a state that allows them to, and to fight for the maintenance of that right should revocation ever become a legitimate threat.
Despite the impact the 2016 election will have on access to cannabis medicine, I continue to stress that it is paramount to understand that cannabis is inherently medicine and can remain so even in a domineering recreational market.
My question to the masses is no longer “how can we access cannabis,” but “how do we want to access it?” The answer—be it from a personal backyard grow, the local dispensary, or the local pharmacy via a doctor’s prescription—will determine what standards need to define the recreational markets and what further legislative actions need to take place to preserve medical programs.
My answer would be that people should get to choose for themselves how they access their cannabis medicine from a diversified marketplace. But if we let the government decide, there will likely no longer be a choice.
I am hopeful that more states will adopt cannabis legalization, but my express wish is that they mindfully legalize in ways that benefit their people and not just their bottom lines.
Do you agree with Dr. Knox? Sound off and let me know on Twitter @kwild.
This article was originally published on BlackEnterprise.com.
Sit back and vibe with us.
On this flashback episode:
- Bottom line, women are running thangs. Women hold far more executive positions in the cannabis industry than any other industry in the US
-AND why are women choosing cannabis over alcohol? We have a few theories over here.
-Cannabis macaroons. Yes, you read that.
Aubrey’s most loyal fan finally sees Hotline Bling + Fon’s ratchet TV recap.
(via EstroHaze Podcast on Soundcloud)
Dr. Rachel Knox is passionate about cannabis. As an M.D. with formal training in family and integrative medicine, in addition to having an MBA, she is also a cannabis specialist and the co-founder of the Canna MDs, with her sister Dr. Jessica Knox. Dr. Rachel Knox counsels over 500 patients per month in medical cannabis care and has witnessed cannabis play a significant role in helping patients gain control of, not only their health, but also obtain an overall sense of wellness in their lives.
As such, she is on a mission to destigmatize cannabis use as a safe, effective, and powerful way to heal. I recently chatted with Dr. Rachel to get her thoughts on what the rising federal administration’s views on cannabis mean for the industry. While she believes it’s too early to tell, there are a few concerns.
“It’s evident that medical cannabis and access remain on legislators minds as more states are adopting medical laws. But, in some states where adult (recreational) use has been legalized, we are seeing medical programs [getting] phased out,” she claims.
As “big pharma” positions itself to enter the industry as a major player, one that the federal government has a history of working with, stakeholders—such as patients, cultivators, manufacturers, dispensaries, and legislators—must take a step back and think about what this means for the industry and their respective interests.
Here’s more from our interview with Dr. Rachel Knox:
What are a few factors we should consider in 2017 on the medicinal front?
Dr. Knox: I wish I had a crystal ball to show me what will happen, but while I don’t, I do anticipate that big pharma will attempt to stake a claim in ownership over cannabis as medicine, as state-sanctioned recreational markets devalue the medicinal essence of cannabis. We are already seeing this happen in states like Washington, where the state has enacted allowable limits of common chemicals found in fertilizers, pesticides, and other cultivation products, and has, additionally, prohibited the use “medical cannabis” on all product labels.
So, what does that mean?
Dr. Knox: This means that cannabis and the products made from it are allowed to contain toxic chemicals—to an allowable degree—that, quite honestly, render them non-medicinal. As such, I advise my patients to use only organic, pure, whole plant cannabis and cannabis products that are 100% free of toxic chemicals. You cannot expect to heal from a product that has even trace amounts of toxic elements; this is counterproductive.
Yet, I also believe that the big industry players know this, as well. As recreational products become less medicinal, I do believe we will see big pharma stepping in, as the gatekeeper to cannabis “medicines.”
Is big pharma’s entrance into the market a bad thing?
Dr. Knox: I don’t know for certain, but what I do know for sure is that it’s an incredibly nuanced thing, with plenty of negative implications to match any good ones. However, if I had to choose just one area of concern with big pharma, it would be their lack of care in understanding and respecting natural, whole plant medicine, and the common person’s autonomy in using it.
I do not like how big pharma, the FDA, and big medicine distort, down-play, and discredit natural medicine. Cannabis has been rigorously tested and is considered significantly safer than tobacco and alcohol, and even less addictive than candy and caffeine! What is notable is that these products are all considered toxic, yet are free for public purchase and consumption. To the contrary, because cannabis heals, there has been a monumental struggle to make it mainstream, but not also without restrictive regulation. Where is the logic [in that]?
As a doctor, how do you balance being a proponent of medical cannabis and an opponent of big pharma?
Dr. Knox: I am absolutely a proponent of whole plant cannabis medicine and an opponent of big pharma’s control of it. This does not mean that I don’t advocate for standardization of processing and responsible oversight—I absolutely do, as should we all, because this is integral for mass adoption by patients and healthcare providers alike. I simply believe that people have a right to freely access and use—intentionally and safely—cultivated natural elements as medicine, and this includes cannabis.
This article originally appeared on BlackEnterprise.com.
Meet Jeannette Ward, former seven-year Coca Cola career climber who recently took the smart leap into the cannabis industry.
Ward serves as executive director (data and marketing) at MJ Freeway, the market leader in ‘seed to sell’ cannabis compliance software & professional consulting services.
Find out why Ward gave up Coke for cannabis, and what she plans to get in return.
How did you get involved in the cannabis industry?
Ward: I was working with Coca Cola in communications, marketing, and data management. I had a role where I had a little more time than usual so I had an interest in doing some consulting and sharpening my own skills around marketing and pushing the envelope with new technologies and new ways of approaching marketing that people weren’t quite ready for.
I took on consulting clients—one of those clients was MJ freeway. I did that for a few months then they made me an offer to come on full-time. I decided it was a once in a lifetime opportunity.
I was probably not going to see another industry that was going to have the explosive growth that cannabis is going to have. I wanted the opportunity to shape a new industry.
Did you have interest in the industry prior to your career involvement?
Yes and no. I started consuming when I was young and then I stopped consuming because I definitely had the perception in my head that it was drugs, that I was getting high and that it wasn’t the best use of my time and resources.
I went about 18 years without consuming and I wasn’t at all involved in cannabis or the cannabis culture. When I took the job, my mindset was, ‘let adults do what adults want to do.’ Then, I got educated on the plant, and on the medicine, and on the best of what cannabis culture is—- activism and giving back, and building a better industry. I became a convert. This medicine will change the world.
Have you had any backlash given your career choice?
I have. I got asked to be off a board that I was on. I have some friends who no longer respond to me on Instagram or via email. People definitely have their beliefs, and they don’t have the education.
We have the wrong language around it. When you talk about it as getting high or stoners, people have this idea in their mind. Us activists have to do a better job with the language and the education.
Why do you believe there is a lack of color in cannabis?
I’m going to take off my MJ Freeway hat for a second and I’m going to put on my vice chair of the Minority Cannabis Business Association hat. Our point of view is that it’s 3 things:
Now that you’ve entered this new industry, what is your ultimate goal in this space?
I want to do good.
What advice would you have for a young African American entrepreneur looking to enter the cannabis field?
Originally published on BlackEnterprise.com
Veteran and cannabis entrepreneur Tanganyika Daniel is Founder of Jayn Green, a cannabis-infused skincare line for men and women. We chatted with the military veteran and got the 411 on how Jayn Green sparked —no pun intended— her cannabis business guide The Canna Print, and the cannabis documentary she’s producing!
Estrohaze’s Sirita Wright for Black Enterprise
Back at it again with the cannabis entrepreneurs list.
If you missed part 1 click here to catch up. At Black Enterprise we’ve been covering how rapidly the cannabis industry is moving, despite opposition from the federal government. In fact, over 20 states and the District of Columbia have legalized marijuana in some way, shape or form.
Estrohaze’s Sirita Wright for Black Enterprise
Is cannabis really medicine?
Today more than 20 states have legalized medicinal marijuana and three states plus the District of Columbia have legalized cannabis for medicinal and recreational use.
Estrohaze’s Sirita Wright for Black Enterprise
If you know weed, or you’d like to, then you need to know Scott Greiper, CEO of Viridian Capital. Why? Because to know weed is one thing, to make money by being in the know is an entirely different beast.
Estrohaze’s Safon Floyd for Black Enterprise
Some of these names will not be surprising. But each one should enlighten and encourage you to expand your mind about the possibilities within the booming cannabis industry. You and your family, especially if you’re African American, now have a shot at the proposed $44 billion dollars coming to the cannabis space by 2020.
Estrohaze’s Sirita Wright for Black Enterprise
Avid cannabis enthusiast, not to mention the owner of Colorado’s first African American owned marijuana dispensary, Wanda James, recently enlightened EstroHaze.com on the ‘whats and hows’ of entering the booming, novel marijuana industry. Check out what she had to say.
EstroHaze: How would you advise someone who is looking to invest in the cannabis industry, but has absolutely no clue on how to get started or what to invest in?
James: When I think about 2009 and 2016 the industries could not be more different. In 2009, when I started, there were no rules. Everything we did in 2009 we took from the idea of businesses that owned previously. When more dispensaries started opening, then they went back to the legislatures and started enacting different rules and regulations until we had the system that is in place today—which is highly specialized seed to sell tracking. It’s pretty intense these days.
How would you advise someone who is looking to invest in the industry but really has no clue whatsoever about how to get started?
There is no one answer as to how one does this. Everyone has different resources, different circles. A lot of times people want to know how to come up with 6, 10 or 20 million dollars to be able to do this. It’s not about one person being able to do this. It’s about what kind of team can you put together. Just like any other business, work in the industry, get to know people in the industry, network in the industry. Find your expertise in one part of it then find other experts to partner with.
What is the likelihood that someone with little to no 'know how,’ but with great passion for the marijuana industry, can find business/financial success in this blooming industry?
I think what we’re seeing now is that the industry is growing in so many amazing ways, so bloom where you’re planted. Even part of what you do, currently, works in the cannabis industry. For example, if you work in PR & marketing, there are now firms who are just dedicated to PR & marketing for cannabis.
What 5 tips could you offer to the novice cannabis entrepreneur?
We’re back for Episode 7. What’s poppin on the podcast?
- Bottom line, women are running thangs. Women hold far more executive positions in the cannabis industry than any other industry in the US
-AND why are women choosing cannabis over alcohol? We have a few theories over here.
-Cannabis macaroons. Yes, you read that.
Aubrey’s most loyal fan finally sees Hotline Bling + Sam’s aka Fon’s ratchet TV recap.Let’s vibe.
We’re back. What’s poppin on the podcast:
-Newsweek lets us know what’s up –women in the pot biz could make it the first billion-dollar industry that isn’t dominated by men.
-Homeade cannabis lube. Yeah, you read that. :)
-Oregon couple breaks tradition w/a budtender. And we’re over the moon about it, tbh.
-Plus as always…Sam’s ratchet TV recap that has us in tears.
Click play and let’s vibe.
Bear with us. Getting our ducks in a row n shit. :) - MJ
This week on the podcast we’re talking:
-Shakespeare and his trees
-Say NO to synthetic weed
-Surge in apps–we’re hype about Bud & Breakfast
And of course, Sam’s ratchet tv recap + a little pop culture news.
Let’s vibe.
I’m too high. Not at this particular moment (ok, maybe slightly), but, in general, I’ve reached my too high point. My too high isn’t related to the over-consumption of a couple blunts, or weekend marathoning, but to the general state I’ve been in for months attributed to my consistent, disproportionate enjoyment of weed. I’m foggy. I’m dulling. I’m losing something in my essence that I can’t quite put my finger on but I know it’s dwindling and it’s likely because I’m too high.
I’ve been here before—more than I care to admit. I get here often. This is due to my affinity for excess and most often, if not always, prompts cold turkey quitting of something or another. I have to do it. I have to cut whatever that thing is that does whatever it does to cause me to get too anything.
I eat a Blow Pop today; I’d like 2 tomorrow and 3 the next day. I get what I like to call a “sugar bump” by Day 4 which prompts me to quit on day 5 only to return by Day 15. It is my cycle.
I’m afraid it may be cannabis quitting time. Note that this quit is temporary—30 days max, so, it’s more like a hiatus. I will use this hiatus to clear up—to reconnect with my thoughts, my words, my essence, my vibe, all things lying dormant beneath the fog. If I remain loyal to history I will complete this hiatus rejuvenated. I will wonder if my natural high has taken me higher than any blunt has ever done before. I will grow curious and test the hypothesis. I will be disappointed after my first hit of smoke to cleared lungs. I will sink slowly, lowly, in hopes of getting higher. I will proclaim that my natural high seemed a little more elevated, yet I will hit the blunt again to be sure. I will continue to do so until I am too high that I am low again. I will quit cold turkey and repeat.
��Ȱ���V<>@8
Episode 4…better late than never tho.
Let’s vibe.
Sam here.
You’re probably wondering ‘harpo, who this woman?’ well, if you promise to behave, i’ll tell you. i’m 1/3 of the estrohaze clique and when i’m not getting hazy (sometimes when I am) i write. what this means for you, you lucky bastard, is that you will be privy to some of my amazing, how did she think of that, oh my goodness i couldn’t have said it better, where has she been all my life words. *feel free to lower your expectation as i may have overshot here.*
nonetheless, every now and then there will be words and such, by and for raging cannabis enthusiasts.
what will these words and such entail, you wonder? well…i haven’t a clue. i will share whatever it is to be shared at the time.
will i be zooted whilst i share these words and such? maybe. you judging?
will these words make any sense if i am, in fact, zooted? no promises.
will you love me regardless? don’t you darn doubt it.
what is the point? you. aren’t you always?
other members of the EH crew, Charlie and MJ, will pop in to see what’s up with you blazing people from time to time too. welcome them. they are worthy.
that said, i’d like to propose a toast. raise ya spliff high—a little higher than that so i can see it—here is to the beginning of something potent and flavorful. may we all get high off each other’s supply.
Cheers!
don’t be selfish, yo. pass that.
Annnd we’re back! This week on the podcast:
-Luxury delivery aka Potbox
-Secret ways women have used weed throughout history (Still use some of those today, tbh)
-Tyga’s antics
-Bill Cosby and his woes
Plus Sam’s ratchet TV recap.
Click the link and vibe out with us.
Poppin on the podcast this week:
-one of the best cannabis strains for anxiety
-cotton vagina (We know, sounds dreadful) frown emoticon
-employer gray area with cannabis prescriptions
-how Caitlyn Jenner slayed (we noticed the C, girl)
-a little ratchet tv monday recap
Andddd Cinnamon Jackson joined us for a little smoke and toke.
Jungle and Chip rolled through. We’re just figuring it all out.